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► standard urology care
Abstract Background Coronavirus disease 2019 (COVID-19) has evolved as a pandemic of
unimaginable magnitude. The health care system is facing a tremendous challenge to
provide ethical and quality care. The transformation of the patient-based care to
population-based care during the COVID-19 pandemic has raised ethical dilemma
among urologists. Our objective is to explore the consensus in modified standard
urology care, that can be adopted and applied during COVID-19 and similar pandemic.
Methods We adopted an exploratory study design using secondary data. The data
were extracted from a web-based medical library using keywords “COVID-19,” “severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2),” and “urology.” We identify
and extrapolate (screening, eligibility, and inclusion) the data using PRISMA protocol,
and summarize pandemic standard urology care under four main themes: (1) general
urology care, (2) choice of surgical modality, (3) triage, and (4) urology training.
Result We identified 63 academic papers related to our research question. The
majority are expert opinions and perspectives on urology care. The common consensus
is triage-based urology care and surgeries. Life or organ threatening conditions need
immediate attention. Universal protective measures (personal protective equipment,
safe operative environment) and protocol-based patient care are necessary to prevent
and control SARS-CoV-2 infection. Conservation of the resources and its rational
distribution provide an ethical basis for population-based health care during a
pandemic. Informed decision making serves best to patients, families, and society
during the public health crisis.
Conclusion COVID-19 pandemic tends to transform standard urology practice into
crisis standard population-based care. The consensus in crisis is drawn from evolving
pieces of medical evidence and public health ethics. The provision of urology care
during a pandemic is based on the availability of resources; severity of the disease,
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The occurrence and the outcomes of the COVID-19 (corona-
virus disease-2019) pandemic have been unprecedented.
Worldwide it has infected 4,864,881 people and has caused
321,818 deaths till May 20, 2020.1 The health care system is
confronting an ethical dilemma of scarce resource allocation,
triage of care, and professional duty to care.2,3Majority of the
non-COVID health problems have been neglected. Catering
COVID-19, as well as non-COVID care, is part of robust
hospital preparedness and response plan.
The relationship between COVID-19 and urology is mul-
tifaceted and dynamic.4 The rapid surge in the COVID-19
cases has caused redistribution and reorganization of the
health services (including urology). As the pandemic keeps
evolving the impact becomes unpredictable and the benefit
often becomes incomprehensible.5,6 In the meantime, the
essential and nondeferrable urology care needs a modified
but rational approach. The basis of prioritization and dura-
tion of deferral, the consequences of deferral and delay, the
success of alternative modes of medical and surgical treat-
ment are largely unanswered.6 The emerging and evolving
scientific evidence helps formulating guidelines for urology
case management. This systematic review aims to organize
crisis standard evidence that would assist in informed deci-
sion making for a urologist, during COVID-and post-COVID
pandemic era.
Methods
The present systematic review was conducted based on the
PRISMA protocol (►Fig. 1). Online database till May 20, 2020
(Medline, Google Scholar, and EMBASE) was searched with
keywords—“COVID-19,” “SARS-Cov-2,” coronavirus in com-
bination with “Urology.” The titles and abstracts were inde-
pendently reviewed by three authors to identify the
potentially related articles. The full texts were reviewed
and data summary (the type of article, place of publication,
target topics heading in urology, and recommended guide-
line) were tabulated and result generated.
The studies includedwere about: (a) general urology care,
(b) choice of surgical modality, (c) triaging urology care, and
(d) training. The literature with inaccessible full-text and
non-English research articles was excluded. “Pandemic stan-
dard urology care” and its guiding principles were tabulated.
Results
Out of 63 academic articles, 30 papers are related to general
urology care, 16 are about thebenignurological condition, 11
about uro-oncology, and six about urology training. The
majority of the articles are expert opinions and perspectives.
Only 16 articles are original research papers.We grouped the
research papers according to the objectives and the informa-
tionwere analyzed to summarize the recommendations. The
current recommendation for pandemic standard urology
care is drawn from limited scientific evidence. The new
standard of care exclusively aims to prevent and control
COVID-19 infection, protect occupational health, and opti-
mize scarce resources by continuing the life and organ saving
treatment and interventions. The consensus guidelines for
crisis standard urology care based on the above principles
keep evolving as this pandemic progress.
General Urology Care
The health care system needs to set a clear plan of action in
response to COVID-19 pandemic settings (►Table 1). Mini-
mal risk exposure for the safety of health care workers, fair
distribution and conservation of resources, strategic repur-
posing of the surgical services including operating theaters,
and professional solidarity among health care workers are
necessary to charter health care during a pandemic.7,8
Reconfiguring elective surgeries conserves resources and
provides extra space, stuff, and, staff for COVID care.9,10
Urological care based on clinical condition and calculated
risk provides an ethical basis of a treatment plan. Inter-
department collaboration, transparent communication, and
surge capacity contingency can address unforeseeable chal-
lenges during a pandemic.9 Education and training prepares
and motivates health care workers in duty.5,9 Surgical staff
Table 1 General guidelines for urological care during COVID
pandemic4,5,7–9,11,14–16,20,23,27,29,52,53
• Ensure adequate essential personal protection
equipment.
• Postpone elective/ nonessential surgeries.
• Reduce outpatient visit.
• Triage patients analyzing risk benefit and through in-
formed decision making.
• Simplify diagnostic and staging process.
• Education and training of health care staff.
• Conservation of resources.
• Reorganization of operation room structure and function.
• Collaboration among surgical allied unit to find common
solution.
• Prepare contingency plan or surge capacity to meet the
emerging crisis.
• All operative cases should be tested for COVID.
• Separate COVID-19 positive patients from noninfected
patients in each level of care.
• Procedures in local anesthesia or spinal block whenever
possible.
• Equitable and fair distribution of operation room and the
critical care resources.
• Adopt nonsurgical or open surgical procedure to laparo-
scopic procedure.
• Maintain negative room pressure and air filters during
minimal invasive procedure.
• Surgeries should be performed by experienced surgeon
outside learning curve.
• Avoid transrectal diagnostic procedure (ultrasound, digi-
tal rectal examination).
• Consider minimal hospital visit to patients.
• Defer all types of systemic chemotherapy.
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can be kept reserve when not required. Telemedicine (pa-
tient consultation, multidisciplinary conference, and elec-
tronic database) is a viable option to mitigate the risk of
exposure and contact-free care.9
Different levels of personal protective equipments are
available for health care workers. Maximum utilization of
the personal protective equipment can be done depending
upon the various level of transmission risk (low, moderate,
and high).11,12 Operating on COVID-19 positive cases needs
adequate planning, precaution, and execution. The impor-
tance of PPE (personal protective equipment), negative pres-
sure room, minimal personnel movement, disinfection and
sterilization, and viral filters was underscored in mitigating
the risk.4,13–15 Emergencies and oncology cases must be
continued with judicious use of an operating room and
strained critical care resources.5,9,10,16 Reorganizing opera-
tion theater and rescheduling the surgeries depending upon
the volume of cases, available resources, and expertise allow
for efficient patient management and exposure risk
reduction.7,8
Infection prevention and control is the arduous task in
health care settings. The key steps of the infection control
during surgical care are: thorough hand washing, environ-
mental cleaning, patient decolonization, vascular care, and
surveillance. For environmental control, combination of
deep cleaning with surface disinfectants using quaternary
ammonium compound and alcohol is recommended.17 Suf-
ficient air exchanges (20 cycles per hour) are necessary to
reduce the particles and viral load.14 For patient decoloniza-
tion, preoperative chlorhexidine wipes, two doses of nasal
povidone-iodine within 1 hour of incision, and a chlorhexi-
dine mouth rinse are recommended.17 The standard of
sterilization and disinfection for reprocessing instruments
should not be compromised. All endoscopic instruments are
subjected to “high-level disinfection” to kill severe acute
respiratory syndrome corona virus-2 (SARS-CoV-2) that
causes COVID-19 disease.18
Choice of Surgical Modality
The least invasive intervention modalities that can be com-
pleted in local or regional anesthesia will serve the best
interest of patients and urologists.10,14 Endoscopic surgery is
considered relatively safe. However, the closed-system suc-
tion evacuation of irrigation fluid is required. Necessary
precaution is taken not to cause iatrogenic trauma that could
compromise endourological procedure and its outcome.
Disposable equipment and supplies are preferred over reus-
able ones.14 Aerosol generating procedure needs extra pre-
caution and level III personal protection. Ultrasonic scalpels
produce a large amount of water vapor, aerosols, and smoke
formation.19 Monopolar with inbuilt smoke evacuator pro-
vides protection. It is highly recommended to ensure meas-
ures to avoid body fluid spillage during surgery and
measures to protect from it.11,14,20,21 Frequent suction of
smoke and use of ultralow particulate air filter (ULPA) are
recommended. Pneumoperitoneum should be set atminimal
acceptable pressure. The leak in pneumoperitoneum should
be avoided and prevented. Balloon trocar can prevent air
leak. Laparoscopic trocar and specimen need careful removal
when pneumoperitoneum is still present.21 The experts are
skeptical about the use of two-way insufflations system like
air seal that defy ULPA filter function.14 Open surgeries are
preferred over minimal invasive surgeries (laparoscopic and
robotic) provided the risk does not outweigh the benefit.19,22
Triaging Urological Care
Triaging the urology services during a pandemic crisis has
drawn the attention of more scholars. The principles guiding
the urology care during the COVID-19 pandemic are listed
in ►Table 2. The prioritization and categorization of the
urological care are enumerated in ►Table 3. Experts have
proposed prioritization of urological surgeries into five
tiers23 (0, emergency and 4, nonessential) or four tiers11
[low, high, emergency, and nonessential]) to provide treat-
ment triage during an ongoing pandemic. The decision of
deferring or undertaking urological cases and surgeries
should be guided by public health-focused ethical consider-
ation.16,23 Backed by informed decision, local context, and
impact of the global pandemic on the health system one or
the entire four tiers can be stopped, paused, or continued.
Outpatient Urology Care
The outpatient visits should be reduced to a minimum.
Progressively deteriorating disease conditions or organ or
life-threatening conditions are only recommended to visit
the urology clinic. “Telehealth-integrated patient manage-
ment protocol” is encouraged.24,25 Virtual clinics have been
proposed for the continuation of essential outpatient care.
Radiological investigation and cystoscopy for an emergency
condition like gross hematuria and urosepsis should not be
deferred.26
The office-based diagnostic procedures (flexible cystos-
copy, pressure flow studies) for the benign condition can be
deferred. The outpatient urological procedures like prostate
Table 2 Principles and ethical values behind urology care
triage during pandemic4,11,14–16,23,29,45,52
• Status of SARS-CoV-2 test and COVID-19 disease
condition.
• Trend of pandemic in local context and calculated risk of
exposure.
• Disease severity or stage.
• Prognosis by deferring.
• Available alternative treatment modalities.
• Resources (human, capital, and infrastructure) availability
and utilization.
• Expected total hospital stay, recovery, and number of
follow-up visit.
• Expected complications and strain to the critical care unit.
• Risk of exposure during referral or deferral.
Abbreviations: COVID-19, coronavirus disease 2019; SARS-CoV-2, se-
vere acute respiratory syndrome coronavirus 2.
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biopsy follow-up cystoscopy, replacement of ureteral stents
and nephrostomy tube, and intravesical therapy for low-risk
nonmuscle invasive bladder cancer (NMIBC), and NMIBC
patients who have already completed 1 year of maintenance
therapy can be deferred.16,23,27,28 However, the risk and
benefit need to be evaluated with informed decision
making.5,11
Emergency Urological Care
Urological emergencies are either organ threatening or life
threatening and cannot be deferred. Necessary personal
protective measures are taken before embarking on inter-
ventions. Consideration is given to the least invasive proce-
dure with a minimum operative time that can be conducted
in the local or regional anesthetic block. Themajorityof these
emergency urological conditions are minor surgeries,
endourological, and percutaneous procedures done under
local or regional anesthesia without delay.11,23,29 Tefik et al
advise to manage obstructing urolithiasis depending upon
the status of renal function, infection, and pain.30
Uro-Oncology
The majority of the urological malignancies are given high
priority and the required intervention is strongly
Table 3 Urology care triage and recommendation5,11,16,22,23,29,31,32,38–40,42–45,49,50
Nondeferrable/Emergency/
Life threatening
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recommended.16,23,29,31 Urological surgeries can be triaged
on basis of the COVID-19 test, cancer stage, the outcomes of
delaying, and the provision of alternative treatment modali-
ties.16,31 One-third to two-third of the planned oncology
surgeries have been rescheduled during the COVID-19 pan-
demic.11,22,23,31 Systemic chemotherapy is better avoided
due to high risk of immunosuppression. Alternative thera-
pies like immunotherapy, target therapy, and hormonal
therapy are considered safer. Radiotherapy that requires
repeated health care center visit is discouraged.22,27 Intra-
vesical therapy for bladder cancer is strictly limited to the
high-risk groups.11,28,32 Interventional diagnostic and fol-
low-up procedures for the low-risk in terms of outcome
(prostate biopsy, surveillance cystoscopy, and intravesical
therapy) can be deferred safely.5,11,29 Low-risk disease that
otherwise can be taken for surgeries can be put on active
surveillance.22
Benign Urological Condition
Except for emerging complications, the majority of the
benign urological condition can be postponed until the
pandemic ends.15 Nonurgent urolithiasis intervention can
be deferred. But urolithiasis with symptoms and complica-
tions required urinary diversion or symptomatic relief.30 All
types of surgeries for benign prostatic enlargement (endo-
scopic and minimal invasive) are classified nonessential and
the acute condition can bemanagedwith temporary bladder
diversion.16 A serious concern is made by academician
regarding men’s health.33–35 Witherspoon and colleagues
recommended individual consideration for care of: male
infertility, testicular mass, testicular pain, sperm banking,
and testicular deficiency syndrome.36,37
Elective renal transplant surgery is not advisable during
the acute phase of the current pandemic.15,38 Ritschl et al39
has elaborately mentioned about the recommendation for
Fig. 1 PRISMA Protocol for Systematic Review.
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both donor and recipients of solid organ transplant including
kidney. Complete epidemiological, clinical, and laboratory
investigation of the donor and recipients are strongly rec-
ommended. No active COVID-19 cases should be considered
for transplant surgery. Deceased donor transplantation
(even from recovered COVID-19 cases) needs careful
consideration.16,39
Residency Training
Urology residency training is compromised as the services
are reduced and limited to nondeferrable cases. It has caused
stress among medical students as all the medical examina-
tions and academic rounds are currently postponed.15 How-
ever, online presentation, discussion and telecast;
simulation training; and virtual congressional meeting are
actively fulfilling the gap and are popularly in the prac-
tice.40,41 This pandemic is going to be there for quite a
long time before any therapeutic or chemopreventive mea-
sure is discovered. Nassar and colleagues recommended the
“functional-restructuring” of the residency program in the
era of COVID pandemic to optimize the patient care and
maintain the morale of residents.42 Continued medical edu-
cation to update the COVID-19 knowledge and skills (includ-
ing critical care, palliative care, resource conservation, and
ongoing clinical trials) is necessary. Residents need to care for
personal safety and mental health; adopt telehealth and
virtual learning; and supplement training with medical
ethics, health policy, and global health.43 Fifty-five percent
of the urologist in training in France reported mental stress
due to COVID pandemic.44Maintaining thehealthy reserve of
residents is necessary to mitigate burn out.43
Discussion
Guidelines Office Rapid Response Group (GORRG) of Euro-
pean Association of Urology (EAU) has divided the elective
urological surgeries based on clinical harm down the time-
line (low risk, no harm by 6 months; intermediate risk, no
harm by 3 to 4months, and high risk, no harm by 6weeks).45
The epidemiology of COVID-19 is rapidly changing and
unpredictable. The effect of rescheduling the procedures
can have a unique clinical outcome in each patient and is
not easy to predict exactly for a span of timeframe. Risk of
contracting and spreading the infection and benefiting the
individual patient should be cautiously balanced. Prioritizing
the urological care and selecting the modality of surgical
intervention during this pandemic should be based upon
available scientific evidence and local socioeconomic con-
text.10,16,31 We should not forget that the best available
armamentarium for primary prevention is social distancing
and personal protection equipment. The “test-trace-isolate”
is another effective secondary prevention modality. Infectiv-
ity andmortality of SARS-CoV-2 virus need to be understood
well. The 30-day postoperative outcomes were reported by
the COVIDsurg collaborative from the international cohort
(24 countries). They found 71.5% (806 out of 1,128) SARS-
CoV-2 infection and 51.2% of pulmonary complications in the
postoperative period with an overall mortality rate of 23.8%.
The risk factors for complicationswere older age (>70 years),
male gender, emergency surgeries, and malignant surger-
ies.46 The overallworldwidemortality rate ranges from2.3 to
5.6% and significantly higher in the age group >80 years
(8%).14 The SARS-CoV-2 virus was also isolated from stool
and urine (6.9%) of the COVID positive patient.47,48
Urological malignancy and the transplant candidates are
most vulnerable to the disease progression as well as to the
COVID-19 exposure.16,39 The major triaging criteria for
malignancy are its prognosis and provision of alternative
treatment modalities and utilization of resources.16 It
requires informed clinical decisions and contingency. Active
screening of the malignancy is not recommended.22 The
shortage of intravesical therapeutic agents for NMIBC (BCG
- Bacillus Calmette–Guérin) can be addressed by using the
alternative agent (mitomycin c) in selected cases or by
reducing the dosage of the intravesical BCG to half to
one-third.49 The emergency conditions need to be managed
efficiently and effectively without adding the extra risk of
exposure and extra burden to health care resources. Human
is both victim and vector of SARS-CoV-2. No age is immune.
Pediatric urology too needs pandemic standard care.24,50
Higher risk population group should avoid visiting the
outpatient department. Malignant diseases are at higher
risk than benign (p¼0.001).40 Telemedicine (video visit,
virtual check-in, eVisit, and eConsult) not only provides
zero risk urology services during a pandemic but also has
the potential to grow into telemonitoring (cystoscopy,
video-urodynamic, radiodiagnosis) and telesurgery (robotic
surgery).51 Based upon the risk grading, a study in Germany
found that 54.1% of the patients in Germany were eligible
(based on risk grading) and willing for tele-consultation for
urology care that will ensure “contact-free continuity of
care”.25 Besides convenience, efficiency, and cost-utility the
long-term quality health care (efficacy, safety, and equity)
provided by the telehealth is not known.51 All the urologists
including the residents in urology should quickly learn and
adopt the changing context of the health care system to
serve patients and to save themselves.42–44
We have included the current scientific evidence and
academic articles in this review to make it comprehensive
and simple. Evidence-based health care is the integration of
research studies, clinical experiences, expert opinions, and
patient values. The lower level (expert’s opinion and con-
sensus statements) of current evidence justifies the crisis
standard approach. This is not the first and probably not the
last pandemic of this world. Our review would provide
important guidance and motivation for further scientific
research to frame robust urology preparedness and re-
sponse plan. Current evidence and guidelines are based
on high-impact countries, mainly Europe and the United
States (60%). This reserves room for reporting and publica-
tion bias and wider external validity. Further experiences
and evidence from all corners of the world could help to
draw more suitable and adoptable consensus among urol-
ogists worldwide. Observing and deferring what we cur-
rently assume nonessential could add new insight to the
natural history of the disease.
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Conclusion
Balancing the crisis standard public health protection and
individual clinical care is a big challenge. Triaging urology
care is the best approach during a public health crisis.
Informed decision making in health care has paramount
importance during a pandemic. The COVID-19 pandemic
has provided ample opportunity to learn, unlearn, and
relearn the science. It is also time to plan a resilient health
care system appropriate for the public health crisis which
could afflict humankind time and again.
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